Sabrina A. Assoumou

Health and Economic Outcomes of Addressing Encampments of Individuals Using Opioids

At the intersection of trust and mistrust: A qualitative analysis of motivators and barriers to research participation at a safety‐net hospital

Economic Evaluation of Extended-Release Buprenorphine for Persons With Opioid Use Disorder

Peer recovery coaching for comprehensive HIV, hepatitis C, and opioid use disorder management: The CHORUS pilot study

Development and validation of predictive models for COVID-19 outcomes in a safety-net hospital population

Barriers to accessing treatment for substance use after inpatient managed withdrawal (Detox): A qualitative study

Long COVID and Health Inequities: The Role of Primary Care

Projected Estimates of Opioid Mortality After Community-Level Interventions

Characterizing initiation, use, and discontinuation of extended-release buprenorphine in a nationally representative United States commercially insured cohort

HIV Pre-exposure Prophylaxis and Buprenorphine at a Drug Detoxification Center During the Opioid Epidemic: Opportunities and Challenges

Early administration of interleukin-6 inhibitors for patients with severe COVID-19 disease is associated with decreased intubation, reduced mortality, and increased discharge

HCV Testing and Treatment in a National Sample of US Federally Qualified Health Centers during the Opioid Epidemic

Cost-effectiveness and Budgetary Impact of Hepatitis C Virus Testing, Treatment, and Linkage to Care in US Prisons

Cost-Effectiveness of One-Time Hepatitis C Screening Strategies Among Adolescents and Young Adults in Primary Care Settings

Cost Effectiveness and Cost Containment in the Era of Interferon-Free Therapies to Treat Hepatitis C Virus Genotype 1

The Cost-Effectiveness of Sofosbuvir-Based Regimens for Treatment of Hepatitis C Virus Genotype 2 or 3 Infection

The Hepatitis C Cascade of Care: Identifying Priorities to Improve Clinical Outcomes